Hatakeyama Shota, Koizumi Kaori, Kuramoto Goro, Horiuchi Yoriko, Ohgi Shirei, Yanaihara Atsushi
Department of Obstetrics and Gynecology, Yanaihara Women's Clinic, Kamakura, Japan.
Department of Clinical Regenerative Medicine, Fujita Medical Innovation Center, Tokyo, Japan.
F S Rep. 2024 Nov 23;6(1):17-24. doi: 10.1016/j.xfre.2024.11.006. eCollection 2025 Mar.
To evaluate the impact of assisted sperm fusion insemination (ASFI), a microinsemination method using sperm bound to the zona pellucida (ZP-sperm) without penetrating the oocyte membrane, compared with conventional intracytoplasmic sperm injection (C-ICSI), on fertilization and embryonic development.
Prospective clinical sibling-oocyte study.
A total of 197 oocytes from 24 patients who underwent 35 oocyte retrieval cycles from January 2023 to April 2024 were analyzed. Patients who underwent retrieval of both, at least 2 metaphase II (MII) oocytes and at least 1 immature or degenerated oocyte, were recruited.
Metaphase II oocytes were alternately allocated to 2 groups: ASFI and C-ICSI groups. To obtain ZP-sperm for ASFI, immature or degenerated oocytes were incubated with 10,000 motile sperm for 3 hours. After harvesting the ZP-sperm, it was pressed onto the membrane of an MII oocyte for 10 seconds in the ASFI group. Conventional intracytoplasmic sperm injection was performed conventionally in the C-ICSI group.
The rates of 2 pronuclei (2PN), degeneration, blastocyst formation, and usable embryos, defined as the total number of transferred or cryopreserved embryos divided by the number of MII oocytes, were compared between the 2 groups.
The 2PN rate of the ASFI group was 88.0% (73/83), which was significantly higher than that of the C-ICSI group (70.2% [80/114]). In addition, a significantly lower degeneration rate was observed in the ASFI group (0% [0/83]) than in the C-ICSI group (8.8% [10/114]). The blastocyst formation rate was equivalent in the 2 groups (ASFI group, 63.9% [39/61]; C-ICSI group, 62.0% [44/71]). However, the usable embryo rate was significantly higher in the ASFI group (45.8% [38/83]) than in the C-ICSI group (28.1% [32/114]).
The ASFI group yielded significantly higher 2PN and lower degeneration rates than the C-ICSI group. Consequently, the ASFI group experienced a higher number of embryos usable for implantation, although there was no significant difference in the blastocyst formation rate between the 2 groups. Further studies with a larger number of cases will be needed for more general application of these findings.
评估辅助精子融合授精(ASFI),一种使用结合于透明带的精子(ZP精子)而不穿透卵母细胞膜的显微授精方法,与传统卵胞浆内单精子注射(C-ICSI)相比,对受精和胚胎发育的影响。
前瞻性临床同胞卵母细胞研究。
分析了2023年1月至2024年4月期间24例患者进行35个取卵周期获得的共197个卵母细胞。招募了至少获取2个中期II(MII)卵母细胞和至少1个未成熟或退化卵母细胞的患者。
将MII卵母细胞交替分配到2组:ASFI组和C-ICSI组。为获得用于ASFI的ZP精子,将未成熟或退化卵母细胞与10000个活动精子孵育3小时。收集ZP精子后,在ASFI组将其压在MII卵母细胞膜上10秒。C-ICSI组按常规进行传统卵胞浆内单精子注射。
比较两组的双原核(2PN)率、退化率、囊胚形成率以及可用胚胎率,可用胚胎率定义为移植或冷冻保存胚胎总数除以MII卵母细胞数。
ASFI组的2PN率为88.0%(73/83),显著高于C-ICSI组(70.2%[80/114])。此外,观察到ASFI组的退化率(0%[0/83])显著低于C-ICSI组(8.8%[10/114])。两组的囊胚形成率相当(ASFI组,63.9%[39/61];C-ICSI组,62.0%[44/71])。然而,ASFI组的可用胚胎率(45.8%[38/83])显著高于C-ICSI组(28.1%[32/114])。
ASFI组的2PN率显著高于C-ICSI组,退化率更低。因此,ASFI组有更多可用于植入的胚胎,尽管两组的囊胚形成率无显著差异。为使这些发现更广泛应用,需要进行更多病例的进一步研究。